Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study

[1]  Joann G. Elmore Md Mph,et al.  Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health , 2020 .

[2]  T. Kauko,et al.  Cerebrospinal fluid cytokines in Lyme neuroborreliosis , 2016, Journal of Neuroinflammation.

[3]  L. Moravcová,et al.  Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections , 2016, Journal of the Neurological Sciences.

[4]  A. Ciorba,et al.  Facial nerve paralysis in children. , 2015, World Journal of Clinical Cases.

[5]  H. Pfister,et al.  Lyme neuroborreliosis—epidemiology, diagnosis and management , 2015, Nature Reviews Neurology.

[6]  H. Tumani,et al.  The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis , 2015, Fluids and Barriers of the CNS.

[7]  M. Verbeek,et al.  Has CXCL13 an added value in diagnosis of neurosyphilis? , 2015, Journal of clinical microbiology.

[8]  K. Rostásy,et al.  Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. , 2015, JAMA neurology.

[9]  J. Puustinen,et al.  CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation , 2014, Journal of Neuroinflammation.

[10]  C. Lechner,et al.  [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. , 2014, Der Nervenarzt.

[11]  C. Lechner,et al.  CXCL13 als Biomarker der akuten Neuroborreliose , 2014, Der Nervenarzt.

[12]  I. Yilmaz,et al.  P128 – 1627 Overview of pediatric peripheral facial nerve paralysis: analysis of 40 patients , 2013 .

[13]  M. Philipp,et al.  Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain , 2013, Mediators of inflammation.

[14]  H. Sarvas,et al.  Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children , 2013, Scandinavian journal of infectious diseases.

[15]  V. S. Wong,et al.  CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. , 2013, Blood.

[16]  K. Blennow,et al.  Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection , 2013, BMC Neurology.

[17]  S. Cepok,et al.  CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation , 2012, Journal of Neuroinflammation.

[18]  A. Berghold,et al.  CXCL13 chemokine in pediatric and adult neuroborreliosis , 2011, Acta neurologica Scandinavica.

[19]  A. Berghold,et al.  Serum CXCL13 chemokine is not a marker for active Lyme borreliosis. , 2011, Acta dermato-venereologica.

[20]  M. Djukic,et al.  Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis , 2011, Journal of Neurology.

[21]  H. Pfister,et al.  A prospective study on the role of CXCL13 in Lyme neuroborreliosis , 2011, Neurology.

[22]  F. Bakels,et al.  Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid , 2011, Journal of Clinical Microbiology.

[23]  J. Ernerudh,et al.  Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. , 2011, The Journal of infection.

[24]  K. Braun,et al.  Clinical presentation of childhood neuroborreliosis; neurological examination may be normal , 2010, Archives of Disease in Childhood.

[25]  C. Marra,et al.  CXCL13 as a Cerebrospinal Fluid Marker for Neurosyphilis in HIV-Infected Patients With Syphilis , 2010, Sexually transmitted diseases.

[26]  V. Fingerle,et al.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis , 2010, European journal of neurology.

[27]  H. Pfister,et al.  The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis , 2009, Journal of Neuroinflammation.

[28]  A. Ludolph,et al.  The chemokine CXCL13 in acute neuroborreliosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  J. Ernerudh,et al.  Lyme Neuroborreliosis in Children: A Prospective Study of Clinical features, Prognosis, and Outcome , 2008, The Pediatric infectious disease journal.

[30]  U. Ljøstad,et al.  RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS , 2008, Neurology.

[31]  U. Ljøstad,et al.  Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis , 2007, European journal of neurology.

[32]  H. Pfister,et al.  The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis , 2005, Neurology.

[33]  Ira Schwartz,et al.  Diagnosis of Lyme Borreliosis , 2005, Clinical Microbiology Reviews.

[34]  P. Fitzgerald-Bocarsly,et al.  The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis , 2005, Annals of neurology.

[35]  P. Bossuyt,et al.  The diagnostic odds ratio: a single indicator of test performance. , 2003, Journal of clinical epidemiology.

[36]  S. Cepok,et al.  The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. , 2003, Archives of Neurology.

[37]  Steven McGee,et al.  Simplifying likelihood ratios , 2002, Journal of General Internal Medicine.

[38]  O. Clemmensen,et al.  Diagnostic Value of PCR for Detection of Borrelia burgdorferi DNA in Clinical Specimens From Patients With Erythema Migrans and Lyme Neuroborreliosis , 2000, Molecular Diagnosis.

[39]  E. Boltshauser,et al.  Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis , 1997, Neurology.

[40]  H. Christen.  Lyme neuroborreliosis in children. , 1996, Annals of medicine.

[41]  M. Karlsson,et al.  Borrelia burgdorferi‐specific intrathecal antibody production in neuroborreliosis , 1993, Neurology.

[42]  A. Lebech,et al.  The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. , 1992, Brain : a journal of neurology.

[43]  S. König,et al.  Follow‐up of antibiotically treated and untreated neuroborreliosis , 1990, Acta neurologica Scandinavica.

[44]  R. Martin,et al.  Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years , 1989, Journal of Neurology.

[45]  J. Jeanneret,et al.  B. burgdorferi in Switzerland. , 1987, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[46]  B. Hemmer,et al.  Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases , 2013, Journal of Neurology.

[47]  B. Luft,et al.  Lyme borreliosis. , 1994, International journal of antimicrobial agents.